The impact of male sex as a risk factor on the efficacy of treatment for thyroid malignancies
Background. Over the recent decades, more than 30 global staging systems and prognostic models have been developed to predict treatment efficacy in patients with thyroid malignancies. Male sex stands out as one of the primary prognostic factors. The purpose of the study was to evaluate the impact of male sex as factor that worsens treatment prognosis in patients with thyroid malignancies. Materials and methods. 2,300 patients with thyroid malignancies were enrolled. The study groups were stratified according to the stage of the primary tumor (T factor) and the degree of morphological differentiation (D). All patients underwent comprehensive treatment and prolonged screening. To determine the significance of risk factors using modern methods of medical statistics, patients’ clinical and morphological characteristics were evaluated, as well as 5-year survival rates. Results. It was revealed that with an increase in the primary tumor stage, the proportion of male patients increases with statistical significance; the male-to-female ratio in the intrathyroidal T1–3a tumor group is 1 : 5.1, and in advanced Т4b tumor group, it is 1 : 1.2. It has been demonstrated that in groups of advanced extrathyroidal tumors, there is a clear correlation showing poorer 5-year survival rates in men compared to women. A statistically significant deterioration in survival was identified in men with poorly differentiated Т4а stage tumors. A multiple logistic regression mathematical model was proposed to calculate the significance of the investigated factors and predict survival over 5 years. The male sex factor S was investigated; the quality of the model was demonstrated via ROC analysis, yielding a high AUC value (0.8). Conclusions. Male sex is more substantial risk factor in cases of advanced thyroid malignancies and low morphological tumor differentiation. It is more important than initial extrathyroidal Т3b tumor extension, regional metastasis, and advanced age. The male sex holds a critical position among other factors in predicting treatment efficacy for thyroid malignancies.
Authors
- Т.Yu. Yuzvenko (ORCID: https://orcid.org/0000-0003-4229-2075)
- О. А. Товкай (ORCID: https://orcid.org/0000-0002-1329-279X)
- І. В. Дейнеко (ORCID: https://orcid.org/0000-0002-3120-0983)
Institutions
- Regional Clinical Hospital named after II Mechnikov (UA)
Publication Details
- Journal
- INTERNATIONAL JOURNAL OF ENDOCRINOLOGY (Ukraine)
- Published
- 2026-11-14
- DOI
- https://doi.org/10.22141/2224-0721.22.7.2026.1787
- Primary Topic
- Thyroid Cancer Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00